(BAPR) Innovator SP500 Buffer - - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US45782C8881 • Defined Outcome

BAPR: Options, ETF, Index

The Innovator S&P 500 Buffer ETF - April New (BATS:BAPR) is a defined outcome ETF designed to provide investors with exposure to the S&P 500 Index while incorporating downside buffers. The fund invests at least 80% of its net assets in FLEX Options, which are customizable exchange-traded options contracts. These FLEX Options reference the SPDR® S&P 500® ETF Trust, an ETF that tracks the S&P 500 Index. The funds structure allows it to offer a buffered return profile, potentially limiting downside risk during market declines while capping upside participation.

The ETF is non-diversified, meaning it can concentrate its investments in a smaller number of securities, which may increase risk. The reference asset for all FLEX Options held by the fund is the SPDR® S&P 500® ETF Trust, which seeks to replicate the performance of the S&P 500 Index before fees and expenses. The funds use of FLEX Options enables it to create a defined outcome investment strategy, where returns are tied to the performance of the underlying ETF within specified parameters.

As of the latest data, the fund has approximately $238.49 million in assets under management (AUM). It trades on the BATS exchange under the ticker symbol BAPR, with an average daily trading volume of 16,453 shares over the past 20 days. The funds current price is $44.99, with key technical indicators showing a 20-day simple moving average (SMA) of $45.41, a 50-day SMA of $45.06, and a 200-day SMA of $43.13. The average true range (ATR) is 0.35, indicating moderate price volatility.

Average Volume 20d: 16453 Last Price: 44.99 SMA 20: 45.41 SMA 50: 45.06 SMA 200: 43.13 ATR: 0.35 AUM: 238.49M USD

3-Month Forecast: Based on the current technical and fundamental data, the fund is expected to trade within a narrow range, with support near $43.13 (200-day SMA) and resistance at $45.41 (20-day SMA). The ATR of 0.35 suggests average daily price movements of approximately 0.8%. The funds AUM of $238.49 million reflects moderate investor interest, which could support liquidity. The defined outcome structure of the ETF may attract risk-averse investors seeking S&P 500 exposure with built-in buffers against market downturns.

Additional Sources for BAPR ETF

BAPR ETF Overview

Market Cap in USD 205m
Category Defined Outcome
TER 0.79%
IPO / Inception 2019-03-29

BAPR ETF Ratings

Growth 5y 83.3%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -3.07
Analysts -
Fair Price Momentum 42.46 USD
Fair Price DCF -

BAPR Dividends

No Dividends Paid

BAPR Growth Ratios

Growth Correlation 3m -6.5%
Growth Correlation 12m 92.3%
Growth Correlation 5y 92.4%
CAGR 5y 13.74%
CAGR/Max DD 5y 0.91
Sharpe Ratio 12m 1.32
Alpha -1.40
Beta 0.69
Volatility 24.68%
Current Volume 5.5k
Average Volume 20d 18.5k
What is the price of BAPR stocks?
As of March 15, 2025, the stock is trading at USD 42.77 with a total of 5,501 shares traded.
Over the past week, the price has changed by -2.30%, over one month by -6.68%, over three months by -5.23% and over the past year by +7.29%.
Is Innovator SP500 Buffer - a good stock to buy?
Yes. Based on ValueRay Analyses, Innovator SP500 Buffer - (BATS:BAPR) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 83.26 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BAPR as of March 2025 is 42.46. This means that BAPR is currently overvalued and has a potential downside of -0.72%.
Is BAPR a buy, sell or hold?
Innovator SP500 Buffer - has no consensus analysts rating.
What are the forecast for BAPR stock price target?
According to ValueRays Forecast Model, BAPR Innovator SP500 Buffer - will be worth about 47.5 in March 2026. The stock is currently trading at 42.77. This means that the stock has a potential upside of +11.11%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 47.5 11.1%